Preferences
Related Series
Arkstone OneChoice 2026
Enhancing Provider Decision-Making with Clear, Personalized Pathogen Reporting
Interpreting pathogen and resistance data can be difficult and complex, leading to reduced effectiveness and timeliness of treatment decisions for infectious diseases. Fragmented information and varying levels of provider expertise lead to inefficiencies, potential misdiagnoses, and increased risk of antibiotic resistance. OneChoice by Arkstone aims to deliver clear, patient-tailored reports with actionable treatment recommendations, streamlining decision-making at the point of care. This report explores early feedback from OneChoice customers.
If you don't have a login, getting started is easy.
Project Manager
Kyle Chilton
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2026 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.